Concepedia

Bruce E. Tomczuk

BE

32

Publications

1.5K

Citations

22

H-Index

1991

Active since

Affiliations

Johnson & Johnson (United States)(Current)

South College

Dimensional Imaging (United Kingdom)

Kodak (United States)

Sterling Research Group

Bruce E. Tomczuk is an author at Johnson & Johnson (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1991–2011

32

Publications

32

Discovery and Cocrystal Structure of Benzodiazepinedione HDM2 Antagonists That Activate p53 in Cells

Bruce Grasberger, Tianbao Lu, Carsten J. Schubert et al. · Journal of Medicinal Chemistry · 2005 · 425 citations · Full text

, , +20

JNJ-28312141, a novel orally active colony-stimulating factor-1 receptor/FMS-related receptor tyrosine kinase-3 receptor tyrosine kinase inhibitor with potential utility in solid tumors, bone metastases, and acute myeloid leukemia

Carl L. Manthey, Dana L. Johnson, Carl R. Illig et al. · Molecular Cancer Therapeutics · 2009 · 107 citations

, , +17

Design, Synthesis, and Biological Evaluation of Novel Potent and Selective α<sub>v</sub>β<sub>3</sub>/α<sub>v</sub>β<sub>5</sub> Integrin Dual Inhibitors with Improved Bioavailability. Selection of the Molecular Core

Juan Marugán, Carl L. Manthey, Beth Anaclerio et al. · Journal of Medicinal Chemistry · 2005 · 68 citations · Full text

, , +17

Antagonists that demonstrate species differences in neurokinin-1 receptors.

Kenneth C. Appell, B J Fragale, Jane Loscig et al. · Molecular Pharmacology · 1992 · 67 citations

2-Phenyl-3H-imidazo[4,5-b]pyridine-3-acetamides as nonbenzodiazepine anticonvulsants and anxiolytics

Bruce E. Tomczuk, C. R. Taylor, L. Meredith Moses et al. · Journal of Medicinal Chemistry · 1991 · 60 citations

Rows per page

1–5 of 32